Companies / Aerie Pharmaceuticals Inc
Aerie Pharmaceuticals Inc
AERICIK 1337553
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 8, 2015 | Clarus Lifesciences II, L.P. 10% owner | Sell Open-market sale | Common Stock | $5.44M | -175K -5.00% | 3,324,259 | medium |
| Nov 21, 2022 | Kopczynski Casey C. Executive | Other Sold to issuer | Common Stock | $4.27M | -280K -100.00% | 0 | low |
| Nov 21, 2022 | Kannan Raj CEO | Other Sold to issuer | Common Stock | $3.29M | -216K -100.00% | 0 | low |
| Oct 25, 2013 | Clarus Lifesciences II, L.P. 10% owner | Buy Open-market buy | Common Stock | $3.21M | +321K +10.20% | 3,468,494 | high |
| Nov 21, 2022 | LaRocca John Executive | Other Sold to issuer | Common Stock | $817.2K | -54K -100.00% | 0 | low |
| Nov 21, 2022 | Lang Peter Frederick Executive | Other Sold to issuer | Common Stock | $706.0K | -46K -100.00% | 0 | low |
| Nov 21, 2022 | McGraw Benjamin F III Executive | Other Sold to issuer | Common Stock | $640.3K | -42K -100.00% | 0 | low |
| Jan 5, 2015 | Clarus Lifesciences II, L.P. 10% owner | Sell Open-market sale | Common Stock | $411.6K | -13K -0.38% | 3,509,459 | medium |